The Division of Cancer Treatment and Diagnosis (DCTD) is a National Cancer Institute division that supports development and evaluation of cancer therapies, diagnostics, and translational research programs.
DCTD provides scientific and operational support for oncology clinical trials, including investigational agent development and biomarker-driven strategies. Its programs help translate discoveries into early-phase testing and later-stage evaluation pathways. DCTD oversight emphasizes participant safety, protocol integrity, and standardized reporting expectations. The divisionís involvement supports federally aligned governance and high-quality oncology research execution.